FDA Inspection 1219500 — Michael S. Korenfeld, MD
The FDA completed an inspection of Michael S. Korenfeld, MD on Oct 3, 2023 in Washington, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 3, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Washington, MO (United States)
Additional Details
Clinical Investigator (CI)